Dossier de Presse - Bienvenue sur les sites des coordinations ...
Dossier de Presse - Bienvenue sur les sites des coordinations ...
Dossier de Presse - Bienvenue sur les sites des coordinations ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
AFTERNOON<br />
Laminopathies and dystrophinopathies<br />
1.00 pm - 2.30 pm Poster Walk (Poster list page 18) XSalle Les Gou<strong>de</strong>s<br />
PW2, PW5, PW8, PW11, PW14, PW17, PW20, PW23, PW26, PW29, PW32, PW35<br />
2.30 pm - 4.00 pm Plenary lectures XAuditorium<br />
Chairpersons > Georges Serratrice and Carlo Minetti<br />
2.30 pm-3.15 pm Nicolas Lévy, France<br />
> Laminopathies in human and mouse: from gene <strong>de</strong>fects to therapies<br />
3.15 pm-4.00 pm Kate Bushby, UK<br />
> Treat-NMD and translational research<br />
4.00 pm-4.30 pm Break<br />
4.30 pm-5.30 pm Parallel Symposia<br />
‹New insights in laminopathies XAmphitheatre Callelongue<br />
Chairpersons > Gisèle Bonne and John Vissing<br />
Howard J. Worman, Canada<br />
> MAP kinase signalling and cardiomyopathy in Emery-Dreifuss muscular dystrophy<br />
Chris Hutchison, UK<br />
> Novel functions of emerin in cytoskeleton organisation and gene regulation<br />
Roland Foisner, Austria<br />
> Nucleoplasmic lamin complexes regulate muscle progenitor cells<br />
‹New approaches to the therapy of musclar dystrophy XAuditorium<br />
Chairpersons > Mireille Claustres and Jean-Clau<strong>de</strong> Kaplan<br />
Yvan Torrente, Italy<br />
> Autologous transplantation of engineered muscle-<strong>de</strong>rived CD133+ stem cells<br />
Jamel Chelly, France<br />
> Molecular diagnosis and ex-vivo validation of therapeutic approaches in dystrophinopathies<br />
Isabelle Richard, France<br />
> Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation<br />
‹Innovativ aproaches to therapy XSalle Endoume<br />
Chairpersons > François Rivier and Philippe Gailly<br />
Vincenzo Nigro, Italy<br />
> Systemic <strong>de</strong>lta-sarcoglycan gene <strong>de</strong>livery avoids life long evolution of cardiomyopathy<br />
and muscular dystrophy of Bio 14.6 hamster.<br />
A<strong>les</strong>sandra Ferlini, Italy<br />
> The systemic administration of a low dose of 20M2EPS-AON combinated with novel cationic<br />
polymethyl mathacrylate nanopartic<strong>les</strong> induce the recue of dystrophin expression<br />
in both cardiac and skeletal muscle in mdx murine mo<strong>de</strong>l<br />
Philippe Moullier, France<br />
> A<strong>de</strong>no-associated viral vector genomes persist as episomal chromatin in primate skeletal muscle<br />
5.30 pm-6.30 pm Plenary Lecture XAuditorium<br />
Chairperson > Thomas Sejersen<br />
Steve Wilton, Australia<br />
> Splice intervention therapies for muscle diseases<br />
7.00 pm - 8.00 pm Satellite Symposium<br />
‹New insights in Pompe disease organized by Genzyme XAmphitheatre Callelongue<br />
Chairpersons > Brigitte Chabrol and Jean Pouget<br />
Ans Van <strong>de</strong>r Ploeg, The Netherlands<br />
> Long term clinical experience of Myozyme ® in infants and children with Pompe disease<br />
Pascal Laforêt, France<br />
> Clinical trials update on Pompe disease in adults<br />
David Orlikowski, France<br />
> The point of view of the pulmonologist<br />
Programme > Wednesday, May 28<br />
13
Change language